141 related articles for article (PubMed ID: 20627616)
1. The role of hypoxia inducible factor-1alpha in gynecological cancer.
Seeber LM; Horrée N; Vooijs MA; Heintz AP; van der Wall E; Verheijen RH; van Diest PJ
Crit Rev Oncol Hematol; 2011 Jun; 78(3):173-84. PubMed ID: 20627616
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics of gynecological cancer associated with hypoxia-inducible factor 1α expression: a meta-analysis including 6,612 subjects.
Jin Y; Wang H; Ma X; Liang X; Liu X; Wang Y
PLoS One; 2015; 10(5):e0127229. PubMed ID: 25993275
[TBL] [Abstract][Full Text] [Related]
3. HIF-1α in colorectal carcinoma: review of the literature.
Ioannou M; Paraskeva E; Baxevanidou K; Simos G; Papamichali R; Papacharalambous C; Samara M; Koukoulis G
J BUON; 2015; 20(3):680-9. PubMed ID: 26214618
[TBL] [Abstract][Full Text] [Related]
4. Is the hypoxia-inducible factor pathway important in gastric cancer?
Griffiths EA; Pritchard SA; Welch IM; Price PM; West CM
Eur J Cancer; 2005 Dec; 41(18):2792-805. PubMed ID: 16290133
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS; Simons JW
Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
[TBL] [Abstract][Full Text] [Related]
6. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas.
Hu T; He N; Yang Y; Yin C; Sang N; Yang Q
J Exp Clin Cancer Res; 2015 Feb; 34(1):22. PubMed ID: 25884381
[TBL] [Abstract][Full Text] [Related]
7. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
Na YR; Han KC; Park H; Yang EG
Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells.
Bai H; Ge S; Lu J; Qian G; Xu R
J Obstet Gynaecol Res; 2013 Feb; 39(2):555-63. PubMed ID: 22925504
[TBL] [Abstract][Full Text] [Related]
9. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions.
Xia T; Cheng H; Zhu Y
Ann Clin Lab Sci; 2014; 44(2):134-44. PubMed ID: 24795051
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
12. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases.
Shimomura M; Hinoi T; Kuroda S; Adachi T; Kawaguchi Y; Sasada T; Takakura Y; Egi H; Okajima M; Tashiro H; Nishizaka T; Ohdan H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S527-36. PubMed ID: 23748663
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1α-dependent manner in pancreatic cancer cells.
Hashimoto O; Shimizu K; Semba S; Chiba S; Ku Y; Yokozaki H; Hori Y
Pathobiology; 2011; 78(4):181-92. PubMed ID: 21778785
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
[TBL] [Abstract][Full Text] [Related]
16. The role of hypoxia inducible factor in nasal inflammations.
Cheng KJ; Bao YY; Zhou SH
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5067-5076. PubMed ID: 28051265
[TBL] [Abstract][Full Text] [Related]
17. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
18. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Kuijper A; van der Groep P; van der Wall E; van Diest PJ
Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts.
Dang DT; Chen F; Gardner LB; Cummins JM; Rago C; Bunz F; Kantsevoy SV; Dang LH
Cancer Res; 2006 Feb; 66(3):1684-936. PubMed ID: 16452228
[TBL] [Abstract][Full Text] [Related]
20. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
